Please assess the completion status of the following clinical trial:

Trial Title: Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* last menstrual period between 6 months and 3 years before the beginning of the study plus FSH levels higher than 35 IU/L;~* age between 42 and 58 years;~* no use of any medication known to interfere with hormonal, glucose, or lipoprotein levels in the past 3 months;~* no use of steroidal or no steroidal anti-inflammatory drugs in the last 15 days.~Exclusion criteria:~* patients with diabetes,~* previous hysterectomy,~* endometrial thickness \>0.5cm,~* history of cancer,~* thromboembolism, or~* established cardiovascular disease

- Gender: FEMALE
- Minimum Age: 42 Years
- Maximum Age: 58 Years
- Healthy Volunteers: t

Study Arms:
- Non-oral hormone therapy (Type: ACTIVE_COMPARATOR): 3 mg/day intranasal estradiol daily or 1,5 mg/day transdermal estradiol and 200 mg/day vaginal micronized progesterone for 14 days/month
- oral homone therapy (Type: ACTIVE_COMPARATOR): estradiol 1mg and drospirenone 2 mg/day

Based on this trial design, predict the completion outcome and termination type (if applicable).